Martin F Fey - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Martin F Fey

Showing results (11-20 of 70) with videos related to

Pageof 7

Sort By:

Leukemia & Lymphoma|August 5, 2004

Allelotyping in B-cell chronic lymphocytic leukemia (B-CLL)Urban Novak, Andreas Tobler, Martin F Fey

Leukemia Research|November 19, 2011

Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cellsJasmin Batliner, Emanuel Buehrer, Martin F Fey, et al.

Swiss Medical Weekly|November 25, 2010

Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?Mathias Jenal, Christian Britschgi, Martin F Fey, et al.

European Journal of Cancer (Oxford, England : 1990)|July 20, 2005

Pneumococcal vaccination in splenectomised cancer patientsAurelius G Omlin, Kathrin Mühlemann, Martin F Fey, et al.

Leukemia Research|September 18, 2012

Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cellsMagali Humbert, Chantal Mueller, Martin F Fey, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 15, 2011

Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomitingHenning Burmeister, Stefan Aebi, Cristina Studer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003

Assessment of differences in patient populations selected for excluded from participation in clinical phase III acute myelogenous leukemia trialsCatherine Mengis, Stefan Aebi, Andreas Tobler, et al.

Experimental Hematology & Oncology|December 6, 2012

BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiationAnna M Schläfli, Bruce E Torbett, Martin F Fey, et al.

Cell Research|December 21, 2011

Autophagy is required for self-renewal and differentiation of adult human stem cellsSouzan Salemi, Shida Yousefi, Mihai A Constantinescu, et al.

Current Opinion in Oncology|August 6, 2024

Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trialsMartin F Fey, Seamus O'Reilly, Ahmad H Awada, et al.

Pageof 7

Search research articles

Showing results (11-20 of 70) with videos related to

Sort By:

Pageof 7

Leukemia & Lymphoma|August 5, 2004

Allelotyping in B-cell chronic lymphocytic leukemia (B-CLL)Urban Novak, Andreas Tobler, Martin F Fey

Leukemia Research|November 19, 2011

Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cellsJasmin Batliner, Emanuel Buehrer, Martin F Fey, et al.

Swiss Medical Weekly|November 25, 2010

Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?Mathias Jenal, Christian Britschgi, Martin F Fey, et al.

European Journal of Cancer (Oxford, England : 1990)|July 20, 2005

Pneumococcal vaccination in splenectomised cancer patientsAurelius G Omlin, Kathrin Mühlemann, Martin F Fey, et al.

Leukemia Research|September 18, 2012

Inhibition of damage-regulated autophagy modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cellsMagali Humbert, Chantal Mueller, Martin F Fey, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 15, 2011

Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomitingHenning Burmeister, Stefan Aebi, Cristina Studer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003

Assessment of differences in patient populations selected for excluded from participation in clinical phase III acute myelogenous leukemia trialsCatherine Mengis, Stefan Aebi, Andreas Tobler, et al.

Experimental Hematology & Oncology|December 6, 2012

BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiationAnna M Schläfli, Bruce E Torbett, Martin F Fey, et al.

Cell Research|December 21, 2011

Autophagy is required for self-renewal and differentiation of adult human stem cellsSouzan Salemi, Shida Yousefi, Mihai A Constantinescu, et al.

Current Opinion in Oncology|August 6, 2024

Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trialsMartin F Fey, Seamus O'Reilly, Ahmad H Awada, et al.

Pageof 7